High blood pressure (BP) is one of the crucial determinants of the metabolic syndrome (MS). The extent to which MS, diagnosed according to the criteria of the International Federation of Diabetes, impacts on cardiovascular organ damage, independently of BP, is debated. Three hundred and forty hypertensive patients and 100 normotensive controls underwent the following procedures: (1) physical examination and resting BP measurements, (2) 24 h ambulatory BP monitoring, (3) laboratory routine examination, (4) echocardiography, (5) carotid ultrasonography and (6) ankle-brachial BP index. The syndrome was found in 104 of the 340 hypertensive patients (30.6). In comparison to those without MS, those with MS had significantly higher prevalence of left ventricular (LV) hypertrophy by mass/height 2.7 criteria (46 vs 42%, Po0.01) but not by LV mass/body surface criteria (30 vs 31%); the ratio between early-to-late peak velocities of the LV filling waves (E/A) was higher (E/ A ¼ 0.9970.14 vs 0.8970.15, Po0.01) and left atrium was larger (3.870.3 vs 3.570.5 cm, Po0.01). Both hypertensive groups had significantly greater LVM and carotid intima-media thickness than normotensives, without between-group-difference. In this hypertension outpatient clinic almost one-third hypertensive patients have MS. They show a deterioration in structure and function of the heart in comparison to hypertensive patients without MS, but no difference was detected in the carotid and peripheral arterial circulation.
Introduction
In the last decade the relation of insulin resistance and the consequent hyperinsulinemia to cardiovascular disease has been described in several studies with different terms. [1] [2] [3] [4] The attempt to reconcile the variety of relationships of metabolic and haemodynamic risk factors to cardiovascular disease is under a more generic paradigm of the relationship between metabolic syndrome (MS) and cardiovascular abnormalities. 5 In this regard, therefore, definition of MS is a key factor. Among things disputed, there is the question whether MS is a robust and clinically useful tool or a poorly defined set of conditions is under debate. 6 Adult Treatment Panel III suggested to standardize criteria for diagnosis of MS. 7 However, new or modified definitions have been proposed by the European Group for the Study of Insulin Resistance, 8 by the American College of Endocrinology 9 and by the International Diabetes Federation. 10 The aims of the present study were to evaluate the following in a sample of patients consecutively seen from the hypertension outpatient clinic of our department:
(a) the prevalence of MS, diagnosed according to the IDF criteria; (b) the extent to which left ventricular (LV) structural and functional abnormalities are associated with MS by IDF criteria in comparison to hypertensive patients without MS and to normotensive controls; (c) the extent of the lesions in the carotid and lower limb arterial circulation in comparison to hypertensive patients without MS and to normotensive controls.
Patients and methods
The study group initially comprised 400 hypertensive patients (patients with blood pressure (BP) levels 4140/90 mm Hg in at least three occasions or under antihypertensive treatment), consecutively seen in the Hypertension Outpatient Clinic of the Department of Clinical and Experimental Medicine of Naples in a time window of 2 years. The study protocol was approved by the local Ethics Committee and informed consent was obtained from all participants in the study. Of the initial cohort, 107 (26.7%) had never received antihypertensive treatment before entering the study. All patients on treatment at the screening visit with a single drug at submaximal dose and without well-controlled BP underwent a 1-month washout after giving informed consent and were included in the study. Exclusion criteria were:
(a) biochemical or instrumental evidence of secondary hypertension; (b) history of cardiovascular events; (c) evidence of other chronic diseases such as liver cirrhosis, renal failure, endocrinology diseases (d) pregnancy or lactation.
After patients gave the informed consent to participate in the study, entered the run-in, when their blood pressure at rest was measured three times at 2-week intervals. At the end of the run-in, they underwent the following measurements: height and weight, using a platform beam-scale (Seca 760); body mass index (BMI) was calculated as weight-to-squared height ratio (w/h 2 ); office BP, using an automatic sphygmomanometer (Sentron, Bard Biomedical Division, CR Bard Inc., Lombard, IL, USA). Two blood pressure readings were recorded with patients in the sitting position for at least 5 min, between 0900 and 1100 h in the morning; the average of the two readings was considered as the measurement for that visit; twenty-four hour ambulatory blood pressure monitoring (ABPM), by Spacelabs Inc. 90207 (Redmond Washington, USA), during a normal working day, as already published. 11 The monitor was fitted on in the morning, between 1000 and 1200 hours Subjects were asked to perform their normal daily activities and to consume their habitual diet. After calibration, the monitor was programmed to record BP and heart rate (HR) at 15-min intervals during the subjects' waking hours and at 20-min intervals during their usual sleeping hours. Subjects were instructed to keep their arm still during recordings. For the analysis of the data, the 24-h measurements were divided into waking (0700-2245 h) and sleeping (2300-0640 h) periods. The 24-h record was acceptable if more than 80% of the scheduled readings were available. Patients also filled in a 24 h diary to report daily activities and rest, including the sleeping period. According to average nightime BP fall relative to daytime average pressure, patients were defined as 'dippers' when night time mean (diastolic blood pressure (DBP) þ 1/3 (systolic blood pressure (SBP)ÀDBP)) BP fall was 410% of the mean daytime BP; laboratory assessment of fasting serum glucose (FBG), total serum cholesterol (Chol), triglycerides (TG) and high-density lipoprotein (HDL)-cholesterol. Blood samples were drawn at 0830 hours, after an overnight fast. Cholesterol content in the low-density lipoproteins (LDL-chol) was calculated by the Friedewald formula 12 as follows:
Two-dimensionally targeted M-mode echocardiograms were performed by an expert sonographer, using a commercially available echocardiograph (AU3 Partner ESAOTE Biomedica, Florence, Italy) connected to a 2.5-3.5 MHz annular-array transducer and recorded on videotapes. Strip-chart tracings of the patients were obtained at 50 mm/s velocity; these were examined by two experienced investigators blind to the knowledge of the status of patients, using a graphic tablet and a pointer device interfaced with a PC and a customized data-acquisition software. In our laboratory, the interobserver variability for measurements of wall thickness, internal dimensions and LV mass was very small with an interclass correlation coefficient of 0.90. End-diastolic and end-systolic LV internal diameters, posterior wall (PWT) and septal thickness were measured according to the recommendations of the American Society of Echocardiography. 13 A second set of measurements was also taken according to the Penn convention criteria to calculate left ventricular mass (LVM).
14 LVM was indexed to body surface area, 15 and left ventricular hypertrophy (LVH) was diagnosed when LVM was above the partition values of X116 g/m 2 for men and X104 g/m 2 for women. 16 Moreover LVM was also indexed to height to the power of 2.7 to detect LVH more related to increased body weight and LVH was diagnosed when LVM was above the partition value of 49.2 g/m 2.7 in men and 46.7 g/m 2.7 in women. 17 Relative wall thickness, an index of LV geometric pattern, was measured at end diastole, as 2 Â PWT/LVIDD. The aortic root was measured according to the recommendations of the American Society of Echocardiography. Left atrium size was measured from the trailing edge to the leading edge, by excluding the posterior wall of the aortic root. LV end diastolic and systolic volumes were calculated using the Teichholz correction of the cube formula. 18 LV chamber and stroke volumes determined using this approach have been shown to correlate well with invasive and with Doppler echocardiographic volume measurements in a variety of populations with symmetric LV wall motion. 19 Cardiac output and ejection fraction were also calculated.
Pulsed Doppler echocardiography
After M-mode recordings, pulsed Doppler echocardiography was performed. Transmitral flow velocity waveforms were obtained from the apex in the fourand five-chamber projection with the sample volume placed at the level of the mitral annulus and at the tip of the mitral valve leaflets. The angle between the Doppler beam and the assumed direction of the transmitral flow was less than 101 in all subjects. The peak of the early diastolic velocity (E) and the late diastolic wave (A) were measured in m/ s and their E/A ratio was determined. The flow velocity-time integral of early diastolic flow, that of late diastolic flow were also calculated. 20 Carotid ultrasound imaging was performed with a 2000 II SA Biosound ultrasound system (Bio Dynamics, Indianapolis, IN, USA) according to the methodology already described. 21, 22 Ultrasonographic images were considered acceptable only if they met the criteria for a high-quality examination, that is:
(a) presence of the adventitia-media interface and intima-lumen interface in at least two arterial segments; (b) visualization of anterior, posterior, lateral and medial wall of the common carotid artery, the bifurcation and at least 2 cm of the internal carotid artery.
The whole scanning procedure was recorded on a videotape; a hard copy of the distal portion of the common carotid artery, just below the bulb, was thereafter produced. Pictures were scanned (Epson G 2000) and displayed on a computer screen (Macintosh II) and then analysed by a software (Image 1.31), which allows quantitative evaluation of the terminal centimetre of the vessel intimamedia area. Measurement of mean intima-media thickness (IMT) of the common carotid arteries was derived from the area-to-1 cm length ratio. Lumen diameter was also measured at the same level. Thickness of the common carotid artery was measured only at the level of the far wall (the carotid wall farthest from the probe) as this segment is more constantly visualized with B-mode imaging than the more superficial near wall. 11, 12 This technique allows a high reproducibility of the measurements, as already shown in a previous study. 23 Peripheral artery assessment of significant atherosclerosis The resting ankle-brachial pressure index (ABPI) was measured with the subject in supine position with an 8-MHz continuous-wave Doppler probe. The value of the highest systolic blood pressure measured at the ankle was divided to the highest blood pressure measured in both arms. The ratio (ABPI) was calculated for both legs.
Hypertensive patients who entered the study were divided in two subgroups -those with and those without metabolic syndrome -according to the IDF criteria.
10 MS, therefore, included patients with waist circumference 494 for men and 480 cm for women plus at least two of the following FBG X100 mg/dl (5.6 mmol/l), HDL-cholesterol o40 mg/ dl (1.04 mmol/l) for men and o50 mg/dl (1.30 mmol/l) for women, total TG X150 mg/dl (1.69 mmol/l), systolic blood pressure4130 or diastolic blood pressure485 mm Hg or use of antihypertensive treatment.
The protocol of the study had been approved by the local Ethics Committee and informed consent was obtained by all participants in the study. Difference between non-parametric variables was assessed by w 2 -test. Multiple linear regression analysis was used to allow for confounders using E-wave and E/A as dependent variables.
Statistical analyses

Results
Of the initial 400 hypertensive patients, 60 were excluded because they could not discontinue antihypertensive treatment or had echocardiogram and/ or carotid EchoDoppler of suboptimal quality. Three hundred and forty patients (79%), 136women, 204men, therefore, entered the study group. A group of 38 women and 62 men, comparable for age and sex to the study group, normotensive and without metabolic syndrome served as control group. It included patients who were seen in the day hospital for diseases other than hypertension, other metabolic diseases or their cardiovascular complications. Among hypertensive patients, subjects with metabolic syndrome (MS þ ) were 104 according to the IDF criteria. The groups of hypertensives were, obviously, different for all parameters entering in the definition of MS. Characteristics of the groups and BP are shown in Table 1 .
By echocardiography, hypertensive group MS þ had larger left atrium and aortic root and reduced ejection fraction than those MSÀ. The prevalence of LVH was similar (32 vs 29% in the groups without and with MS) when the indexation to BSA was used. On the contrary, the indexation of LVM to h 2.7 showed a slightly higher prevalence of LVH in the group of hypertensive patients with MS (41 vs 47%). Prevalence of LVH in the control group was 14 and 24% using the indexation to BSA or to height to the power of 2.7, respectively. Hypertensive patients with concomitant MS had a significantly lower peak velocity of the early LV filling wave without differences in the peak velocity of the atrialdependent LV filling wave. E/A was, consequently, significantly lower in MS þ hypertensives than in hypertensives without MS. Differences between controls and subjects with and without metabolic syndrome were statistically significant (Po0.01) ( Table 2) . Among the possible different covariates which might influence E-wave and E/A, only age was able to affect both (Po0.001), while sex significantly affected E-wave (Po0.01) and HR significantly affected E-on-A (P ¼ 0.02). BP, other metabolic variables entering in the definition of metabolic syndrome and LV mass did not account for differences in LV diastolic function among groups.
Carotid ultrasound imaging showed no significant differences among the three groups with regard to IMT and diameter of both right and left common carotid artery. No differences were also seen with regard to ABPI as well ( Table 3 ). The corresponding figures for the control group are shown in the same table and are similar to those of hypertensive patients apart from a reduced mean and peak IMT.
Discussion
The present study, whose background and main results in the perspective of future research are summarized, was performed in 340 consecutive patients, spontaneously attending the hypertension outpatient clinic of our department. Prevalence of metabolic syndrome in this type of sample was expected to be very high, as already observed in other hypertension clinic: it averaged, in fact, to 32% in the present study, very close to that of 30.2% observed by Cuspidi and colleagues. 24 This prevalence is significantly higher than that previously observed by us in a general population, which averaged to 20%. 25 In the same study, we detected that prevalence of MS in the hypertensive group was even higher (39%) than in the present investigation: this finding is not unexpected since it is conceivable that hypertensive patients attending an outpatient clinic control their BP, body weight and glucose and lipid metabolism more accurately than hypertensive patients observed in a population setting.
This first observation immediately brings us to a second point regarding the clinical role of the metabolic syndrome, independently of hypertension and diabetes, which had been recently disputed. 26, 27 There is no doubt that high blood pressure is a very frequently observed component of the syndrome, the most frequent in the Gubbio Population (87%) and very frequent in the peculiar population of the Pima Indians (61%), who are mainly characterized by obesity (91% of the sample) and diabetes (55.6% of the sample). 28 In the present study, BP levels at rest and during 24 h were similar in the hypertensive groups with and without MS and significantly higher in comparison to normotensive controls. The presence of hypertension confers an increased risk of cardiovascular disease, independently of the association with other metabolic abnormalities, as shown by the increase in the MS-group of LVM and mean and peak IMT to a same extent of that observed in hypertensive patients with MS, in comparison to normotensive controls. This observation suggests that hypertension, from mild to severe, is able per se to explain most of the early C-V abnormalities detected in patients with MS. Nevertheless, this study highlights also that hypertensive patients with MS have impaired diastolic function, particularly the early phase of the diastolic filling, and increased left atrium dimensions, even after the indexation to BSA, in comparison to hypertensive patients without MS. These findings are in agreement with previous observations by other authors and ourselves, since left atrium dimensions had been found related to hypertension associated to metabolic abnormalities 29 and impairment of the diastolic function had been observed in subjects with increased insulin resistance 30 as well as in diabetic patients. 31 Moreover, these findings also confirm that myocardial dysfunction increases according to the number of risk factors: 32 in the case of MS there are at least three concomitant cardiovascular risk factors.
Regarding the presence of LV hypertrophy in patients with MS, it mostly depends on the indexation of LVM we use. As expected, that to h, 2.7 which particularly enhances the role of body weight as determinant of LVH, increases the prevalence of LVH in the group with MS, since this group had significantly higher BMI. In this case the hypothesis that clustering of metabolic factors of the syndrome enhances the influence of underlying factors, as insulin resistance, on myocardial thickening would be further supported. 33 A fourth point of discussion is related to the influence of hypertension on carotid arteriosclerosis. From previous investigations there is no doubt that high blood pressure has a pivotal role in the carotid wall thickening. 23, 34 More recently the role of hypertension, in particular of the blood pressure variability during 24 h, in addition to that of the duration of hypertension 35, 36 was strongly supported, even in subjects with metabolic syndrome. 37 The present study is in agreement with these observations, showing that the association of metabolic abnormalities to hypertension adds only a further small impairment to that induced by hypertension. Carotid diameter, on the other hand, was similar in hypertensive patients, with and without MS, and in normotensive subjects. We have already shown that absolute values of carotid diameter in hypertensive patients were similar to normotensive subjects, but when the diameter was corrected by BP values a significant reduction was detected in hypertensive patients, possibly suggesting a decreased distensibility of the carotid wall in these patients. 38 The present observation confirms this finding in hypertensive patients without (4.4) and with (4.3) MS in comparison to normotensive control (4.8) .
Peripheral arterial circulation is not frequently affected by hypertension as opposed to what happens in diabetes. In the present study, including very few people with diabetes, no deterioration of peripheral circulation was detected in MS hypertensive patients, in contrast to studies on MS performed in patients recruited from Diabetic Clinics. 39, 40 Limitations of the study The present study, performed in a hypertension outpatient clinic, obviously carries the flaw of including in the MS -group all patients with arterial hypertension, which is an independent powerful risk factor for cardiovascular damage. Moreover a cross-sectional observation does not allow any definite conclusion regarding the increase in cardiovascular risk due to the presence of metabolic syndrome. We only can suggest that, despite the presence of confounders also in the group of patients without MS, subjects with the syndrome have more evident signs of cardiac dysfunction, potentially able to induce major clinical events.
Highlights of the study
The results of the present study indicate that subjects with arterial hypertension and metabolic syndrome are more exposed than patients with sole hypertension to an increased risk of abnormalities in the early phase of the diastolic filling of the left ventricle with a consequent increase in the dimensions of the left atrium. Carotid arteries are also involved in the syndrome, but to an extent similar to that of patients with the sole hypertension.
With the obesity pandemic, we fear that measurable cardiovascular disease will occur more and more frequently in younger age groups with excess body fat. From the practical point of view, therefore, this study strongly suggests to improve body weight control with the reduction in daily caloric intake in general population, particularly in subjects with familial predisposition to other metabolic abnormalities. Moreover an echocardio-Doppler study is suggested in these subjects to detect early signs of the ventricular filling.
